Skip to main content
Premium Trial:

Request an Annual Quote

Waters Shares Sink 21 Percent After Company Cuts Q1 Earnings Projections

NEW YORK, March 30 (GenomeWeb News) - Shares in Waters today tumbled 21 percent, or $9.71, at $36.55 in mid-afternoon trading one day after the company said it would revise its projected first quarter earnings from $.44 to between $.34 and $.37 per diluted share.

In a 
statement, Waters said that the lowered earnings were the result of "weaker than expected sales growth." The firm had anticipated a 13 to 14 percent increase in sales during a conference call with investors in January, but revised that projection to a 3 to 4 percent increase yesterday.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.